Front Line Medical Technologies, a Canadian medical device company dedicated to improving bleeding control and resuscitation worldwide, has achieved a major milestone with the CE marking of its innovative COBRA-OS® device. This cutting-edge device is the smallest life-saving REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) device available, providing controlled occlusion of a patient’s aorta in critical medical situations. Its compact design, ease of use, and rapid deployment make it an indispensable tool for trauma care professionals.
The COBRA-OS® stands out for its ultra-low profile, eliminating the need for an over-the-wire technique, which significantly speeds up deployment and buys valuable time for patients awaiting definitive care. It comes with a convenient 4 French mini-access sheath kit and a 10 cc sword-handled syringe, further enhancing its user-friendliness.
Dr. , CEO of Front Line Medical Technologies, expressed the company’s excitement over the CE marking, stating that it underscores their unwavering commitment to technological excellence and patient care. He emphasized that the entire team is driven by the desire to save as many lives as possible and that this regulatory achievement is a testament to their dedication.
Dr. , CMO of Front Line Medical Technologies, highlighted the significant advancement that the COBRA-OS® represents in the field of trauma care. Its focus on patient safety, reducing complications, and simplifying aortic occlusion makes it a valuable asset for medical providers.
, Director of Products at Front Line Medical Technologies, emphasized the company’s mission to increase medical access to the COBRA-OS®. The CE marking opens up the EU market, allowing more patients to benefit from this life-saving device. He stated that the company is committed to expanding access on a global scale and will continue to take steps towards touching more lives and improving outcomes.
Front Line Medical Technologies is a Canadian company driven by its commitment to lowering the barriers in bleeding control and resuscitation worldwide. With the COBRA-OS® CE marking, the company has taken a major step towards achieving its mission and solidifying its position as a leading innovator in the field of medical devices.
